Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-639 in Diabetic Neuropathic Pain
NCT01345045Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ABT-639 in diabetic neuropathy, sponsored by AbbVie Inc.. Started Apr 2011; status: completed.
02
Drugs
ABT-639
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01345045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345045.